SAN DIEGO - Dare Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company focused on women's health, has been awarded a Notice of Award of a grant from the National Institute of Allergy and ...

“Our findings demonstrate that the therapeutic vaccine Vvax001 is safe, well-tolerated, and effective in eradicating HPV16-associated CIN3 lesions and clearing the underlying persistent HPV16 ...

The continued decline of Merck & Co.’s HPV vaccine Gardasil in China has come to a head as the New Jersey drug giant is ...

As more cancers are being linked to the human papillomavirus (HPV), including cancers showing up in younger-than-average patients, a local doctor is promoting the use of the HPV vaccine, which is ...

Sens. Elizabeth Warren and Ron Wyden criticized RFK Jr. over how he's handling potential profits from litigation over an HPV ...

Women’s health champions like us cheered in January when the U.S. Preventive Services Task Force (USPSTF) issued a draft ...

Thailand's National Vaccine Institute (NVI) and the Royal Thai College of Obstetricians and Gynaecologists (RTCOG) have reaffirmed the safety of vaccines in response to social media discussions ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.

Cervical cancer, a leading cause of cancer deaths among women, can be significantly reduced through HPV vaccination and regular screening. The Gardasil 9 vaccine is highly effective and recommended ...

The US$4.8 million (AU$7.2 million) program is funded by CEPI to help mitigate the refrigeration requirements that currently hinder equitable global access to mRNA vaccines. Vaxxas’ proprietary HD-MAP ...

CEPI has approved the advancement of the vaccine program following promising ... Vaxxas’ proprietary HD-MAP offers the potential for needle-free vaccination, reduction of refrigerated storage ...

Compared with needle and syringe systems, HD-MAP vaccines are also much easier to administer and are likely to have greater acceptability by healthcare workers and vaccine recipients. Ultimately ...